Potential nondopaminergic drugs for Parkinson's disease.

Advances in neurology

Volumn 91, Issue , 2003, Pages 273-291

  Silverdale, Monty A ^a   Fox, S H ^a   Crossman, A R ^a   Brotchie, J M ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; ANTIPARKINSON AGENT; LEVODOPA; NEUROTRANSMITTER RECEPTOR;

ANIMAL; BASAL GANGLION; BIOLOGICAL MODEL; DRUG ANTAGONISM; DRUG COMBINATION; DRUG POTENTIATION; HUMAN; METABOLISM; NERVE TRACT; PARKINSON DISEASE; PATHOLOGY; PATHOPHYSIOLOGY; REVIEW; SUBSTANTIA NIGRA;

ANIMALS; ANTIPARKINSON AGENTS; BASAL GANGLIA; DRUG THERAPY, COMBINATION; HUMANS; LEVODOPA; MODELS, NEUROLOGICAL; NEURAL PATHWAYS; NEUROTRANSMITTER AGENTS; PARKINSON DISEASE; RECEPTORS, NEUROTRANSMITTER; SUBSTANTIA NIGRA;

EID: 0037208518     PISSN: 00913952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (183)